Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Integrated Analysis of MicroRNA (miRNA) and mRNA Profiles Reveals Reduced Correlation between MicroRNA and Target Gene in Cancer.

Li X, Yu X, He Y, Meng Y, Liang J, Huang L, Du H, Wang X, Liu W.

Biomed Res Int. 2018 Dec 6;2018:1972606. doi: 10.1155/2018/1972606. eCollection 2018.

2.

Identification of microR-106b as a prognostic biomarker of p53-like bladder cancers by ActMiR.

Lee E, Collazo-Lorduy A, Castillo-Martin M, Gong Y, Wang L, Oh WK, Galsky MD, Cordon-Cardo C, Zhu J.

Oncogene. 2018 Nov;37(44):5858-5872. doi: 10.1038/s41388-018-0367-0. Epub 2018 Jul 3.

3.

Treatment-associated TP53 DNA-binding domain missense mutations in the pathogenesis of secondary gliosarcoma.

Pain M, Wang H, Lee E, Strahl M, Hamou W, Sebra R, Zhu J, Yong RL.

Oncotarget. 2017 Dec 20;9(2):2603-2621. doi: 10.18632/oncotarget.23517. eCollection 2018 Jan 5.

4.

miR-500a-5p regulates oxidative stress response genes in breast cancer and predicts cancer survival.

Degli Esposti D, Aushev VN, Lee E, Cros MP, Zhu J, Herceg Z, Chen J, Hernandez-Vargas H.

Sci Rep. 2017 Nov 21;7(1):15966. doi: 10.1038/s41598-017-16226-3.

5.

Novel Predictors of Breast Cancer Survival Derived from miRNA Activity Analysis.

Aushev VN, Lee E, Zhu J, Gopalakrishnan K, Li Q, Teitelbaum SL, Wetmur J, Degli Esposti D, Hernandez-Vargas H, Herceg Z, Parada H, Santella RM, Gammon MD, Chen J.

Clin Cancer Res. 2018 Feb 1;24(3):581-591. doi: 10.1158/1078-0432.CCR-17-0996. Epub 2017 Nov 14.

6.

CR2Cancer: a database for chromatin regulators in human cancer.

Ru B, Sun J, Tong Y, Wong CN, Chandra A, Tang ATS, Chow LKY, Wun WL, Levitskaya Z, Zhang J.

Nucleic Acids Res. 2018 Jan 4;46(D1):D918-D924. doi: 10.1093/nar/gkx877.

7.

A new method to study the change of miRNA-mRNA interactions due to environmental exposures.

Petralia F, Aushev VN, Gopalakrishnan K, Kappil M, W Khin N, Chen J, Teitelbaum SL, Wang P.

Bioinformatics. 2017 Jul 15;33(14):i199-i207. doi: 10.1093/bioinformatics/btx256.

8.

Network-based approaches that exploit inferred transcription factor activity to analyze the impact of genetic variation on gene expression.

Bussemaker HJ, Causton HC, Fazlollahi M, Lee E, Muroff I.

Curr Opin Syst Biol. 2017 Apr;2:98-102. doi: 10.1016/j.coisb.2017.04.002. Epub 2017 Apr 17.

9.

dbDEMC 2.0: updated database of differentially expressed miRNAs in human cancers.

Yang Z, Wu L, Wang A, Tang W, Zhao Y, Zhao H, Teschendorff AE.

Nucleic Acids Res. 2017 Jan 4;45(D1):D812-D818. doi: 10.1093/nar/gkw1079. Epub 2016 Nov 28.

10.

Biological Networks for Cancer Candidate Biomarkers Discovery.

Yan W, Xue W, Chen J, Hu G.

Cancer Inform. 2016 Sep 4;15(Suppl 3):1-7. doi: 10.4137/CIN.S39458. eCollection 2016. Review.

11.

ADAMTS6 suppresses tumor progression via the ERK signaling pathway and serves as a prognostic marker in human breast cancer.

Xie Y, Gou Q, Xie K, Wang Z, Wang Y, Zheng H.

Oncotarget. 2016 Sep 20;7(38):61273-61283. doi: 10.18632/oncotarget.11341.

12.

MiR-7a is an important mediator in Fas-associated protein with death domain (FADD)-regulated expression of focal adhesion kinase (FAK).

Liu Y, Cui H, Huang X, Zhu B, Guan S, Cheng W, Lai Y, Zhang X, Hua ZC.

Oncotarget. 2016 Aug 9;7(32):51393-51407. doi: 10.18632/oncotarget.9838.

Supplemental Content

Support Center